Moalifeplus, Visible Progress in Entering Chinese Market with Its Health Functional Foods

Global healthcare company Moa Life Plus announced on the 9th that it has signed a strategic business partnership agreement with China's Ruiyuan Health Industry Group to jointly research and develop PGA (poly-gamma-glutamic acid) raw materials and promote revenue-generating projects, as well as to sell and distribute its products within China.

Through this agreement, Moa Life Plus aims to develop more eco-friendly and market-friendly products by jointly researching the PGA-K immune functional raw material, recognized by the Ministry of Food and Drug Safety, with Ruiyuan Group. Additionally, by distributing and selling its healthcare products in China through Ruiyuan Group, Moa Life Plus has secured a stable foothold for entering the Chinese market.

Currently, interest in immunity and wellness industries is increasing in China following the COVID-19 pandemic, and healthcare-related businesses are rapidly growing due to aging populations and rising incomes. Accordingly, Ruiyuan Group, which possesses its own proprietary immune functional raw material PGA, has chosen Moa Life Plus as a partner to expand the health functional food market in China.

Ruiyuan Health Industry Group is a subsidiary specializing in healthcare under Ruiyuan Holdings Group, which operates businesses in construction, smart devices, healthcare, manufacturing, real estate, and finance. Ruiyuan Holdings Group is one of the top 100 companies in Shandong Province, recording approximately 6 trillion KRW in sales last year. Notably, the group operates about 500 nursing homes and health screening centers, providing a distribution network for Moa Life Plus’s health-related products in China, which is expected to boost future sales.

Han Sang-jin, CEO of Moa Life Plus, stated, “Through this agreement, we are confident in the global expansion of our immune functional PGA raw material. Moreover, by signing a strategic business cooperation agreement with Ruiyuan Group, which already has a distribution network for healthcare products in China, our goal is to secure a leading position in the Chinese healthcare market.”